All-cause mortality in systemic rheumatic diseases under treatment compared with the general population, 2015-2019.
Vasiliki-Kalliopi Bournia,George E Fragoulis,Panagiota Mitrou,Konstantinos Mathioudakis,Anastasios Tsolakidis,George Konstantonis,Georgia Vourli,Dimitrios Paraskevis,Maria G Tektonidou,Petros P. Sfikakis +9 more
TLDR
In this article, the authors compared current all-cause mortality rates in rheumatoid arthritis (RA), ankylosing spondylitis (AS), psoriatic arthritis (PsA), systemic lupus erythematosus (SLE) and systemic sclerosis (SSc) versus general population.Abstract:
Objectives To compare current all-cause mortality rates in rheumatoid arthritis (RA), ankylosing spondylitis (AS), psoriatic arthritis (PsA), systemic lupus erythematosus (SLE) and systemic sclerosis (SSc) versus general population. Methods In this population-based, retrospective cohort study, anonymised data on 11 186 586 citizens, including all patients with RA (42 735, 79% female), AS (9707, 43% female), PsA (13 779, 55% female), SLE (10 440, 89% female) and SSc (2277, 88% female), (median age of 64/47/54/53/59 years at study entry, respectively), under prescribed treatment between 2015 and 2019, were extracted from the electronic database covering nearly 99% of the Greek population. Results After 1:5 (patients:general population) matching for gender/age, we found that survival was worse in SSc, followed by SLE and inflammatory arthritis. Compared with the general population HRs for death increased from the first 3 years to 5 years of observation possibly due to increases in disease duration: RA (from 0.63 to 1.13 (95% CI: 1.05 to 1.22), AS (from 0.62 to 1.01, (95% CI: 0.76 to 1.33)), PsA (from 0.68 to 1.06, (95% CI: 0.88 to 1.28)), SLE (from 1.52 to 1.98, (95% CI: 1.67 to 2.33)) and SSc (from 2.27 to 4.24, (95% CI: 3.19 to 5.63)). In both SLE and SSc mortality was increased in men than women and in patients younger than 50 years. Conclusions Survival rates over 5 years in inflammatory arthritis under treatment are currently becoming comparable (AS/PsA) or slightly higher (RA) than those of the general population. However, all-cause mortality is almost twofold and fourfold higher in SLE and SSc, respectively, being even higher for male and younger patients.read more
Citations
More filters
Journal ArticleDOI
The second decade of anti-TNF-a therapy in clinical practice: new lessons and future directions in the COVID-19 era
TL;DR: In this article , a large body of additional knowledge has accumulated regarding various aspects of anti-TNF-α therapy, whereas new indications have been added, and the current implementation of the "treat-to-target" approach and treatment de-escalation strategies of IMIDs were based on anti-tNFs.
Journal ArticleDOI
Cardiovascular magnetic resonance in autoimmune rheumatic diseases: a clinical consensus document by the European Association of Cardiovascular Imaging.
Sophie Mavrogeni,Alessia Pepe,Robert J. Nijveldt,Ntobeko A.B. Ntusi,Lilia M. Sierra-Galan,Konstantinos Bratis,J. Wei,Monica Mukherjee,George Markousis-Mavrogenis,Luna Gargani,Leyla Elif Sade,Nina Ajmone-Marsan,Petar M. Seferović,Éanna Donal,Michael T. Nurmohamed,M. Matucci Cerinic,P.P. Sfikakis,G.D. Kitas,Juerg Schwitter,Joao A.C. Lima,Dana Dawson,Marc R. Dweck,Kristina H. Haugaa,Niall G Keenan,James C. Moon,Ivan Stankovic,Erwan Donal,Bernard Cosyns +27 more
TL;DR: The role of CMR in the early and accurate diagnosis of CVD in patients with ARDs compared with other non-invasive imaging modalities is reviewed and a consensus-based decision algorithm for when a CMR study could be considered in patientsWith ARDs is presented, together with a standardized study protocol.
Journal ArticleDOI
Steigt die Prävalenz der rheumatoiden Arthritis wirklich an?
TL;DR: In this paper , a growing number of health insurance data analyses show an increase in the prevalence of rheumatoid arthritis (RA) in Germany in recent years compared to earlier periods.
Journal ArticleDOI
[Is the prevalence of rheumatoid arthritis truly on the rise?]
TL;DR: In this article , a growing number of health insurance data analyses show an increase in the prevalence of rheumatoid arthritis (RA) in Germany in recent years compared to earlier periods.
Journal ArticleDOI
Coronary microvascular disease: The “Meeting Point” of Cardiology, Rheumatology and Endocrinology
TL;DR: The pathophysiology of coronary microvascular disease (CMD) in Cardiology, Rheumatology and Endocrinology was evaluated in this article , and the potential effects of anti-rheumatic and endocrine medications on the evolution of CMD were evaluated.
References
More filters
Journal ArticleDOI
Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force
Josef S. Smolen,Monika Schöls,Jürgen Braun,Maxime Dougados,Oliver FitzGerald,Dafna D. Gladman,Arthur Kavanaugh,Robert Landewé,Philip J. Mease,Joachim Sieper,Tanja Stamm,Maarten de Wit,Daniel Aletaha,Xenofon Baraliakos,Neil Betteridge,Filip Van den Bosch,Laura C. Coates,Paul Emery,Lianne S. Gensler,Laure Gossec,Philip S. Helliwell,Merryn Jongkees,Tore K Kvien,Robert D. Inman,Iain B. McInnes,Mara Maccarone,Pedro Machado,Anna Molto,Alexis Ogdie,Denis Poddubnyy,Christopher T. Ritchlin,Martin Rudwaleit,Adrian Tanew,Bing Thio,Douglas J. Veale,Kurt de Vlam,Désirée van der Heijde +36 more
TL;DR: There was broad agreement, now better supported by data than in 2012, that remission/inactive disease and, alternatively, low/minimal disease activity are the principal targets for the treatment of PsA.
Journal ArticleDOI
Trends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studies
TL;DR: The results confirm that SSc is a devastating condition as reflected by a pooled SMR of 3.5 and that SMR has not significantly changed over the past 40 years.
Journal ArticleDOI
Mortality in rheumatoid arthritis over the last fifty years: systematic review and meta-analysis.
Sabrina Dadoun,Nadine Zeboulon-Ktorza,Christophe Combescure,Muriel Elhai,Sylvie Rozenberg,Laure Gossec,Bruno Fautrel +6 more
TL;DR: Mortality has decreased among RA patients over the past decades but remained higher than in the general population as assessed by the IMR and the SMR over time.
Journal ArticleDOI
Excess mortality emerges after 10 years in an inception cohort of early rheumatoid arthritis.
TL;DR: To investigate mortality rates, causes of death, time trends in mortality, prognostic factors for mortality, and the relationship between disease activity and mortality over a 23‐year period in an inception cohort of rheumatoid arthritis patients, a large number of patients were diagnosed with RA.
Journal ArticleDOI
Early Mortality in a Multinational Systemic Sclerosis Inception Cohort.
Yanjie Hao,Marie Hudson,Murray Baron,Patricia Carreira,Wendy Stevens,Candice Rabusa,Solène Tatibouet,Loreto Carmona,Beatriz Joven,Molla Huq,Susanna Proudman,Mandana Nikpour +11 more
TL;DR: To determine mortality and causes of death in a multinational inception cohort of subjects with systemic sclerosis (SSc), a large number of subjects were diagnosed with at least some form of sclerosis.